RE:TLT-Ruvidar is alone...I hope you know by now no one here has doubts about the science, data and potential. What is missing is credibility due to all the delays, dilution and warrants expiring worthless for those that bought in over the years. I hope for all our sakes that the FDA access via FTD has allowed TLT to fine tune and submit pre-BTD data in a way that is acceptable to the FDA. Any more significant delays beyond Q3 will make it hard for TLT to ever get funding and see this through. We can of course, continue to admire the science for the next decade. In short, let's see how they navigate this submission and BTD approval. Make or break point. They know it as well. Let's hope the FDA finally sees, believes and approves for immediate use.